Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations? - Wikidata - thesis-toulmin - TriplyDB

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

http://www.wikidata.org/entity/Q26771997

about

Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status Considerations Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis

P2860

Q28079207-C2B480D7-F32E-44EF-8E18-3C51EF131E4C Q37165276-55F4206B-7FCB-4364-BB0D-167238AB09EE

P2860

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

http://www.wikidata.org/entity/Q26771997

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@ast

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@en

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@nl

type

label

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@ast

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@en

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@nl

prefLabel

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@ast

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@en

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@nl

P1433

Q26771997-9ABDFCE3-42F8-4459-8597-58B024609F7C

P1476

Q26771997-D0676F48-7472-4E46-9EFD-3B13A20BD9E7

P2093

Q26771997-20AB5BED-4351-4537-A8AB-0789413C301E

Q26771997-7188D34D-C6A9-4FA4-9DC1-42C29887C7E2

P275

Q26771997-16262ABD-0211-412E-A196-77F19CCDC770

P2860

Q26771997-00077FA4-C20B-4403-A0DE-28817F2D51C2

Q26771997-00441D47-1A12-434A-B51B-540EC233E855

Q26771997-0098A16D-E22C-482F-B82A-9288518EADC8

Q26771997-085D71E6-A755-429C-AF3A-6F70D7C87B42

Q26771997-09684D2D-0739-4D1D-B446-861207CE93A7

Q26771997-098ED72E-21C1-40DE-8F8F-0D0AEF0450DF

Q26771997-0B438DAC-5C58-43A9-BF88-57D42929DCB5

Q26771997-12932CA1-9A9F-4F34-8921-0FE197B67C3D

Q26771997-15CC9811-C742-4B5E-B47F-BED17DA18F53

Q26771997-19D8F897-3A4D-42CD-AE6E-8C29E47FDFE6

P304

Q26771997-01C15756-DC45-40BF-A475-26FD1238EBD2

P31

Q26771997-2C57CF5A-B1DC-48A8-A19F-EFA6F2AC26DC

Q26771997-467EA863-1B03-4B30-8748-52E23A039127

P3181

Q26771997-99B8D1CF-019F-4199-8263-309E4A622F6F

P356

Q26771997-CC049C27-B11D-40D8-A9BA-9361C43667CB

P407

Q26771997-EF35D0BF-EDDA-448C-9EB2-F8AFB7B9598D

P433

Q26771997-CA9A081E-E607-4ADC-9734-AFE23828A133

P478

Q26771997-4EBB6FBD-554C-4C68-901E-51C35D9A4687

P5008

Q26771997-00847051-8407-4CBD-ACD9-02046FC8B1DF

P577

Q26771997-05F0E64C-1968-4D13-8371-3B86005DDE22

Q26771997-8EC09BD2-D19C-4CB0-902D-BF730B4484EE

P698

Q26771997-E7D71945-4AAA-4670-997E-3A850A1DFF72

P921

Q26771997-349EB200-D18D-4FCC-8B3A-A216987011F1

Q26771997-58EB8A75-6273-44C0-8908-304D9820AE34

Q26771997-74FE44EF-600F-430E-B728-BD40395216DE

Q26771997-75F92CA3-703E-4FEC-91D3-A5F6F7C28A8B

Q26771997-AA70040F-6369-4473-BFBD-0E2D79515670

Q26771997-E0861489-A194-4BFA-B649-04453A4641EF

P932

Q26771997-A6F5C041-B8DD-413C-8128-5515C6169845

P3181

P356

KJIM.2016.31.1.15

P1433

The Korean journal of internal medicine

P1476

Emerging strategies for the treatment of pulmonary tuberculosis: promise and limitations?

@en

P2093

Wing Wai Yew

http://www.w3.org/2001/XMLSchema#string

Won-Jung Koh

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis

Global epidemiology of tuberculosis

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

Delamanid for multidrug-resistant pulmonary tuberculosis

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India

Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients

Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients

Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosis

Acquired resistance of Mycobacterium tuberculosis to bedaquiline

P304

15-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4377878

http://www.w3.org/2001/XMLSchema#string

P356

10.3904/KJIM.2016.31.1.15

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26767853

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

pulmonary tuberculosis

biomedical investigative technique

Anagraw amesgunef

multidrug-resistant tuberculosis

P932

4712419

http://www.w3.org/2001/XMLSchema#string